Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)
China flag China · Delayed Price · Currency is CNY
30.24
-0.07 (-0.23%)
Apr 30, 2026, 3:04 PM CST

SHE:002864 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,1131,141971.45978.2971.04883.76
Other Revenue
--2.412.633.263.73
1,1131,141973.86980.83974.29887.48
Revenue Growth (YoY)
9.79%17.15%-0.71%0.67%9.78%32.40%
Cost of Revenue
534.23549.08381.74413.74408.25370.36
Gross Profit
578.97591.79592.12567.09566.04517.12
Selling, General & Admin
403.58416.56436.86418.79416.11386.15
Research & Development
51.8953.1137.5420.2618.2314.03
Other Operating Expenses
-2.49-0.169.3510.6110.239.29
Operating Expenses
452.98469.51485.59453.98452.94414.07
Operating Income
125.99122.28106.53113.11113.1103.05
Interest Expense
---1.56-6.11-13.92-3.49
Interest & Investment Income
--25.5822.0617.1811.78
Earnings From Equity Investments
-0.14-0.13----
Other Non Operating Income (Expenses)
-19.31-13.16-0.220.312.55-5.27
EBT Excluding Unusual Items
106.55108.99130.32129.37118.91106.06
Gain (Loss) on Sale of Investments
----1.56-0.11-
Gain (Loss) on Sale of Assets
0.130.13-0.010.17--
Asset Writedown
-0.35-0.17-0.18-0.81-0.08-0
Other Unusual Items
--6.822.080.462.97
Pretax Income
106.32108.95136.95129.25119.18109.03
Income Tax Expense
19.7312.9317.0317.716.0314.47
Earnings From Continuing Operations
86.5996.02119.92111.55103.1594.56
Minority Interest in Earnings
0.20.260.35-1.11-1.98-1.39
Net Income
86.7996.28120.27110.43101.1693.17
Net Income to Common
86.7996.28120.27110.43101.1693.17
Net Income Growth
-27.90%-19.95%8.91%9.16%8.58%17.77%
Shares Outstanding (Basic)
105105105968685
Shares Outstanding (Diluted)
105105105988685
Shares Change (YoY)
-0.15%0.07%7.02%13.03%1.16%-0.60%
EPS (Basic)
0.830.921.151.151.181.09
EPS (Diluted)
0.830.921.151.131.171.09
EPS Growth
-27.79%-20.00%1.77%-3.42%7.34%18.48%
Free Cash Flow
101.5920.674.5441.5369.5335.36
Free Cash Flow Per Share
0.970.200.710.420.800.41
Dividend Per Share
--0.2500.2200.2000.180
Dividend Growth
--13.64%10.00%11.11%20.00%
Gross Margin
52.01%51.87%60.80%57.82%58.10%58.27%
Operating Margin
11.32%10.72%10.94%11.53%11.61%11.61%
Profit Margin
7.80%8.44%12.35%11.26%10.38%10.50%
Free Cash Flow Margin
9.13%1.81%7.65%4.23%7.14%3.98%
EBITDA
163.39158.69139.02142.92130.16117.8
EBITDA Margin
14.68%13.91%14.27%14.57%13.36%13.27%
D&A For EBITDA
37.3936.4132.4929.8117.0714.74
EBIT
125.99122.28106.53113.11113.1103.05
EBIT Margin
11.32%10.72%10.94%11.53%11.61%11.61%
Effective Tax Rate
18.56%11.87%12.43%13.70%13.45%13.27%
Revenue as Reported
--973.86980.83974.29887.48
Advertising Expenses
--5.041.091.763.68
Source: S&P Global Market Intelligence. Standard template. Financial Sources.